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Abstract
Iron oxide nanoparticles are formidable multifunctional systems capable of contrast enhancement 
in magnetic resonance imaging; guidance under remote fields; heat generation; and 
biodegradation. Yet, this potential is underutilized in that each function manifests at different 
nanoparticle sizes. Here, sub-micrometer discoidal magnetic nanoconstructs are realized by 
confining 5 nm ultra-small super-paramagnetic iron oxide nanoparticles (USPIOs) within two 
different mesoporous structures, made out of silicon and polymers. These nanoconstructs exhibit 
transversal relaxivities up to ~10 times (r2 ~ 835 (mM·s)−1) higher than conventional USPIOs and, 
under external magnetic fields, collectively cooperate to amplify tumor accumulation. The boost 
in r2 relaxivity arises from the formation of mesoscopic USPIO clusters within the porous matrix, 
inducing a local reduction in water molecule mobility as demonstrated via molecular dynamics 
simulations. The cooperative accumulation under static magnetic field derives from the large 
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amount of iron that can be loaded per nanoconstuct (up to ~ 65 fg) and the consequent generation 
of significant inter-particle magnetic dipole interactions. In tumor bearing mice, the silicon-based 
nanoconstructs provide MRI contrast enhancement at much smaller doses of iron (~ 0.5 mg of 
Fe/kg animal) as compared to current practice.
Keywords
MRI; magnetic nanoparticles; magnetic guidance; relaxivity; mesoporous matrices
1. Introduction
Iron oxide nanoparticles (IOs) exhibit interesting multi-functional properties that could be 
used in a variety of biomedical applications.[1–3] However, a major impediment to their full 
utilization is that these properties manifest over different, not overlapping, size intervals. In 
magnetic resonance imaging (MRI), IOs with a diameter smaller than 100 nm induce 
significant shortening in transversal relaxation times, T2.[4–8] On the other hand, only 
micron and sub-micron sized IOs have been efficiently manipulated in vivo by remote static 
magnetic fields.[9–13] In therapeutic applications, 20 – 50 nm IOs have been used as 
nanoheaters in that, under alternating magnetic fields, they can generate significant doses of 
thermal energy for ablating the surrounding malignant tissue, sensitizing cells in adjuvant 
therapies, and triggering the release of active molecules.[10, 14–16] Moreover, IOs smaller 
than ~ 20 nm could be fully degraded and metabolized over a few days.[16–19] A novel 
strategy is needed to effectively decouple the IO functions from the particle size in order to 
fully capitalize on the multiple functionalities.
MRI is considered a powerful tool in tumor imaging because of its non-invasiveness and 
high spatial resolution. However, clinically-available products, such as Feridex®, often 
exhibit relatively low transversal relaxivities (r2), typically of about 100 (mM·s) −1.[2, 18] 
Different strategies have been explored to improve the MRI performance of IO-based 
contrast agents, including: the modulation of their size, shape and surface properties; and the 
use of metal alloys. It is well documented that r2 can be enhanced by increasing the size of 
the magnetic core,[20] using cubically-shaped nanoparticles,[16, 21] and decorating the 
particle surface with molecules and polymers.[22] Also, the inclusion of atoms such as Co, 
Mn, Ni in the magnetic core has improved the relaxometric response.[23–25] However, none 
of the listed approaches can successfully combine together the multiple functionalities of the 
IOs. Recently, it has been realized that IO clusters can also provide higher relaxivities when 
compared to individual particles.[26–28] However, such an enhancement is strictly depending 
on the spatial organization and level of hydration of IOs. Moreover, controlling and 
preserving the state of aggregation of the USPIO clusters in vivo, upon systemic injection, 
without compromising their biodistribution are major, unsolved challenges.
Contrast enhancement and therapeutic efficacy are directly related to the amount of IOs 
accumulated at the diseased site. Although IOs with ‘stealth’ coatings tend to circulate 
longer, thus offering a higher probability of passive accumulation within the tumor mass,[2] 
the amount of IOs reaching the tumor site can be much smaller than 1% of the injected dose 
per gram tissue (% ID/g).[29] Remote guidance via external magnetic fields has been 
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proposed as a way to attract more IOs within the target tissue.[9, 13] However, magnetic 
forces scale proportionally to the particle volume and drop rapidly as the IO diameter 
decreases, being negligibly small, as compared to hydrodynamic and colloidal interactions, 
for particles of a few tens of nanometers. Also, the magnetic force reduces with the distance 
from the magnet and the penetration depth.[13, 30] Therefore, not surprisingly, magnetic 
targeting has provided some success only for particles larger than 100 nm and injected doses 
of the order of 10 mg of Fe/kg of animal.[9, 13]
Here, to fully capitalize on the intrinsic multi-functional capabilities of IOs, a novel 
approach is proposed to boost the relaxivity r2; enhance tumor accumulation by remote 
magnetic guidance; and, possibly, enable hyperthermia treatments upon systemic injection. 
This is obtained by dispersing multiple clusters of small USPIOs within the mesoporous 
matrix of larger particles, thus leading to the formation of multiscale, hierarchically-
organized magnetic nanoconstructs. The versatility and generality of the approach is also 
demonstrated by considering two different nanotechnological platforms, namely sub-micron 
sized mesoporous silicon particles (SiMPs) and discoidal polymeric nanoconstructs (DPNs). 
Commercially-available USPIOs are used with a nominal magnetic core diameter of 5 nm. 
The SiMPs and DPNs have been rationally designed to deposit within the tumor vasculature 
by relying on the balance between hydrodynamic dislodging forces and interfacial adhesion 
interactions with the blood vessel walls.[31,32–34] In this manuscript, first, the USPIO 
loading efficiency and the stability of the resulting nanoconstructs have been analyzed, 
under physiologically relevant conditions. Secondly, the relaxometric and magnetic 
guidance response of the nanoconstructs have been characterized in vitro. Finally, for the 
SiMPs which have been extensively tested in vivo,[33–35] the MRI and magnetic guidance 
performance have been demonstrated in a melanoma mouse model using a 3T MRI clinical 
scanner.
2. Results and Discussion
2.1. Assembly of the magnetic nanoconstructs
The schematic representations of our two magnetic nanoconstructs are presented in Figure 
1a, including: discoidal mesoporous silicon particles (SiMPs) with a diameter of ~1,000 nm 
and a thickness of ~400 nm; porous discoidal PLGA/PEG nanoconstructs (DPNs) with a 
diameter of ~1,000 nm and a thickness of ~500 nm. USPIOs with a magnetic core diameter 
of 5 nm were examined for the loading and characterization, with hydrophilic and 
hydrophobic coatings, depending on the host matrix properties. Data on the physico-
chemical properties of the USPIOs, SiMPs, and DPNs are reported in the Supporting 
Information.
The USPIOs are loaded within the SiMP pores via capillary action by directly exposing dry 
SiMPs to a concentrated stock solution of hydrophilic USPIOs; whereas for the DPNs, 
hydrophobic USPIOs are mixed with the polymeric paste during the synthesis process. Note 
that the geometrical and magnetic properties of the hydrophobic and hydrophilic 5 nm 
USPIOs are comparable (Supporting Information). The resulting nanoconstructs were then 
analyzed using TEM, coupled with energy-dispersive X-ray (EDX-TEM), to confirm 
USPIO loading and document on their spatial distribution within the porous matrix. The 
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EDX mappings of Si and Fe for the SiMPs (Figure 1b) show the fine porous structure of the 
nanoconstructs, with lateral and internal walls, and a quite uniform distribution of USPIOs 
(red spots) across the porous matrix. Similarly for the DPNs, Figures 1c demonstrates the 
loading of USPIOs (red dots) within the polymeric matrix. EDX mapping for carbon 
identifies also the external boundaries of the nanoconstructs, as confirmed by the 
corresponding TEM images. The presence of Fe in the two nanoconstructs is also 
documented by EDX spectral analysis and magnetic force microscopy (Supporting 
Information). The images in Figure 1 eloquently show that the USPIOs tend to form 
mesoscopic clusters dispersed throughout the matrix of the resulting magnetic 
nanoconstruct.
The mass of USPIOs loaded per SiMP and DPN is given in Figure 2a: up to 15.5 ± 2.5 × 
10−9 μg of 5 nm USPIOs are loaded per SiMP; and 65.17±4.58 × 10−9 μg are confined 
within the DPNs. Inductively coupled plasma optical emission spectroscopy (ICP – OES) 
was performed on the element Fe for quantifying the mass of loaded USPIOs.
As the USPIO/SiMP nanoconstructs will be later used for in vivo studies, it is here 
important to analyze their stability, in that it is well known that porous silicon spontaneously 
degrades into orthosilicic acid under physiological conditions, thus releasing its 
payload.[36, 37] A stability test was performed by exposing 5 nm USPIO-loaded SiMPs to a 
buffer solution, agitated over time at 60 rpm and 37°C. After 24h of incubation, only 24.0 ± 
2.8% of the originally loaded USPIOs were released upon silicon degradation (Figure 2b). 
SEM images of the magnetic nanoconstructs at different time points during the degradation 
process, namely 3, 6 and 24h, are shown in Figure 2c–e. Significant changes in the SiMP 
geometry are solely visible at 24h. This is consistent with previous data by the authors 
showing that PEG chains, here decorating the USPIOs, modulate the interaction of the 
solution with the silicon walls, thus slowing the degradation process.[37] The stability and 
biodegradation properties of the DPNs have been demonstrated previously by the 
authors.[38, 39]
2.2. Relaxometric characterization of the magnetic nanoconstructs
The authors have recently shown that the geometrical confinement of Gd3+-based MRI 
contrast agents within mesoporous structures enhances their longitudinal relaxometric 
response.[40, 41] To study the effect of USPIO confinement within porous matrices, the 
longitudinal (T1) and transverse (T2) relaxation times of our two magnetic nanoconstructs 
were measured by a bench-top relaxometer operating at 60 MHz (1.41 T) and at 37°C. The 
ability of any material to act as a MRI contrast agent (CA) is expressed in terms of its 
relaxivity ri, defined as the change in relaxation rate of water protons brought about by mM 
concentration of CA. The relaxivities r1,2 of the nanoconstructs were calculated using the 
classical formula r1,2 = (T1,2−1 – T0−1)/[Fe], To being the diamagnetic contribution, and [Fe] 
the iron concentration in mM. Upon confinement within a porous matrix, the USPIOs 
exhibited a significant increase in transversal relaxivity r2 compared to free USPIOs in bulk 
solution (Figure 3a). It increases from 107±24 to 270±73 (mM·s) −1 for the 5 nm USPIOs 
(2.5 times) loaded into the SiMPs. For the DPNs, the transversal relaxivity r2 is 835±63 
(mM·s) −1, which is ~ 10-fold higher than what measured for clinically relevant USPIOs. 
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Note that for the DPNs, the actual r2 enhancement cannot be directly quantified in that these 
nanoconstructs were obtained by dispersing hydrophobic 5 nm USPIOs within a porous 
polymeric matrix. On the other hand, no relevant changes are observed for the longitudinal 
relaxivity r1. A contrast agent is classified as T1-weighted or T2-weighted based on their 
r2/r1 ratio, and a r2/r1 > 2 implies that the agent is more effective as a T2-weighted contrast 
agent.[2] A significant increase in the r2/r1 ratio is observed for all USPIOs upon 
confinement within the porous matrix of the hosting nanoconstructs.
The contrast enhancement efficacy of the magnetic nanoconstructs under clinical settings 
was tested in a 3T MRI scanner (Philips Ingenia®). Figure 3b shows the phantom images for 
different numbers of magnetic nanoconstructs embedded in 1% agarose. The phantom 
images show that the magnetic nanoconstructs are effective under clinical settings, and even 
a small number of nanoconstructs can generate sufficient contrast. For the DPNs, similar 
phantom images are also provided in the Supporting Information. The relaxometric results 
and phantom images demonstrate the superior performance of the nanoconstructs compared 
to free USPIOs in solution.
The observed enhancement in the r2 relaxivity should be ascribed to the hierarchical 
organization of the USPIOs within the hosting matrix (see TEM and EDX analysis in 
Figure. 1 and Supporting Information). Differently from what observed for the longitudinal 
relaxivity enhancement,[40] here, r2 is mostly affected by the formation of USPIO clusters 
and the so called outer sphere mechanism.[42] In general, the transversal relaxivity r2 
increases with the particle magnetization (∝ Ms2) and with the inverse of the diffusion (∝ 
Dw−1) of the water molecules surrounding the magnetic core ( ). However, 
given the hydrophobicity of the polymer (PLGA) forming the cores of the DPNs, the well 
know lower mobility of water molecules within mesoporous structures, and the variety of 
USPIO clusters generated within the two different matrices, it is reasonable to speculate that, 
under such configuration, Dw could play a major role. (Figure. 1 and Supporting 
Information). To better elucidate the mechanisms regulating the r2 enhancement, a 
molecular dynamics (MD) model was developed for the USPIO confinement within 
mesopores. The geometry of the model is depicted in Figure 4a, where an individual USPIO 
is shown first, followed by 1, 4 and 8 couples of USPIOs confined within a periodic slice of 
a mesopore. The model allows for computing changes in the diffusion of water molecules 
Dw as a function of the loading conditions (number of USPIOs per pore slice) and surface 
properties of the USPIOs (polymer chain length and density). Note that the USPIOs form 
multiple mesoscopic clusters in the nanoconstructs, within which the water molecule 
mobility is impaired mostly by geometrical constriction (Figure 4a). Details about the MD 
model are provided in the Supporting Information. The computed coefficient of diffusion, 
Dw, is presented in Figure 4b. The calculations were performed for three strengths of the 
Lennard-Jones (LJ) potential, in order to explore how the observed behavior depends on the 
actual properties of the USPIO surface (i.e. different polymer chain length and density). 
Starting from free bulk water (Dw = 2.7×10−9 m2s−1), the coefficient Dw reduces as the 
number of loaded USPIOs increases, being ~ 2.1×10−9 m2s−1 for 1 couple of USPIOs (25% 
decrease), ~ 1.4×10−9 cm2s−1 for 4 couples of USPIOs (50% decrease), and ~ 0.4×10−9 
m2s−1 for 8 couples of USPIOs (85% decrease). Note that Dw is computed by averaging 
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over the pore cross-section, thus even lower water mobilities are expected in the immediate 
vicinity of the USPIOs, and in the interspaces between the USPIOs and the pore walls. 
These data show that a 85% decrease in the diffusion of water molecules Dw is likely to 
occur in USPIOs-loaded nanoconstructs, and this would already justify a 4-fold increase in 
r2. Remarkably, even a reduction by an order of magnitude in the LJ potential seems to be 
accompanied by only a tiny increase in water mobility. Since the strength of the interaction 
potential is also affected by the adsorption of molecules on the particle surface, the mild 
effect of the LJ potential on Dw would suggest that water confinement is governing the 
relaxivity enhancement. The mechanism proposed above is in agreement with the 
observations of Gillis and colleagues on the magnetic relaxation properties of USPIO 
clusters.[43]
It is here important to emphasize that transversal relaxivities r2 higher than 300 (mM·s) −1 
have been demonstrated with individual, high-performance IOs.[21, 24, 25, 44] However, in 
these cases, the enhancement in relaxivity is mainly due to the improvement of the intrinsic 
magnetic properties of the nanoparticles rather than the modulation of the local water 
mobility. Therefore, it is reasonable to speculate that the geometrical confinement of these 
high-performance IOs within the proposed mesoporous nanoconstructs could boost even 
more their original MRI relaxivities.
2.3. Remote guidance of the magnetic nanoconstructs and cooperative accumulation
The loading data of Figure 2a demonstrate that over 4.0×104 USPIOs are loaded into a 
single SiMP, and this number grows of about 1 order of magnitude, ~ 2.0×105 USPIOs per 
nanoconstructs, in the case of DPNs (5 nm core; USPIO density of 5.17×103 kg/m3). This 
provides a huge, localized concentration of Fe that is equivalent in volume to a spherical 
bead of several hundreds of nanometers in diameter. With these premises, the magnetic 
guidance of our two nanoconstructs under an external static field was tested in a quiescent 
fluid (Supporting Information) and under flow, using a parallel plate flow chamber 
apparatus.[45] This is schematically presented in Figure 5a, showing a flat, cylindrical 
magnet located underneath the chamber. The magnetic nanoconstructs were injected in the 
chamber through the inlet bore using a syringe pump and their dynamics under flow was 
monitored with bright field microscopy. From imaging post-processing (Supporting 
Information), the trajectories and velocities of the nanoconstructs were extracted as a 
function of their initial separation distance from the magnet. The in-plane nanoconstruct 
velocity is decomposed in the longitudinal component, vx, aligned with the flow; and the 
transversal component, vy, orthogonal to the flow and oriented towards the magnet. Figure 
5b shows the normalized velocity vy/(Sh) increasing steadily from zero to about 0.002, 
corresponding to ~ 10 μm/s, at 50 μm away from the magnet. Similarly, the angle θ between 
the flow direction and the particle trajectory varies significantly ranging from 0 to over 30°, 
as the nanoconstruct approaches the magnet. Only minor changes are observed for vx. The 
inset of Figure 5c shows a dark corona originating from the progressive deposition of 
nanoconstructs around the magnet. These pictures have been taken on the flow chamber 
coverslip after the magnet removal. Supporting Videos 1 – 3 document on the rapid 
deceleration and abrupt change in direction experienced by the nanoconstructs as they enter 
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the magnetic field. Interestingly, small clusters of magnetic nanoconstructs, deposited on the 
bottom of the chamber, tend to attract and affect individual nanoconstructs passing nearby.
In order to better characterize the mutual interaction of the nanoconstructs under static 
magnetic fields, the experiments under flow were also performed in the presence of small 
clusters of nanoconstructs pre-formed on the bottom of the flow chamber (green dotted 
circles in Figure 5d and 5f, and Supporting Information at t = 0 min). A few drops of a 
solution containing the nanoconstructs were deposited on the coverslip and left to dry in air, 
while a static magnet was placed underneath the coverslip. After complete drying, the 
coverslip with the pre-formed clusters was assembled with the rest of the parallel plate flow 
chamber apparatus and the actual experiment was performed using a new solution of the 
nanoconstructs. USPIO-loaded SiMPs or DPNs were then injected in the parallel plate flow 
chamber and the size of the four representative clusters was monitored over time (Figure 5e 
and 5g). These experiments were performed in the presence of an external magnetic field 
and, as a control, without any field. Figure 5d and 5f show microscopy images of the region 
of interest at the bottom of the chamber at the initial time (t = 0 min) and at the end of the 
experiment, for SiMPs and DPNs respectively. The relative variation of the area associated 
with four representative clusters (ΔA%) is plotted as a function of time in Figure 5e and 5g. 
The areas of these clusters continuously grow over time demonstrating the progressive 
accumulation of individual nanoconstructs around the pre-formed clusters (see also, 
Supporting Movies 4 and 5). No variation in cluster size and numbers was observed in the 
control experiments, where a magnet was not used (Supporting Information). The magnetic 
nanoconstructs, exposed to remote magnetic fields, tend to behave locally as small, non-
permanent magnetic dipoles. This would enhance locally the magnetic field and its gradient 
favoring particle-particle mutual interaction and attraction. This cooperative mechanism is 
also expected to operate in vivo, favoring the progressive accumulation of nanoconstructs, 
particularly in the smaller blood vessels.
2.4. MR imaging in orthotopic mouse models of melanoma
The MRI and cooperative accumulation properties are demonstrated in vivo for the SiMPs. 
The in vivo performance of SiMPs has been extensively documented in different animal 
models for optical imaging and therapy.[33–35] In particular, the authors have shown that 
discoidal SiMPs of 1,000 x 400 nm can reach tumor accumulation levels of up to 5% of the 
injected dose per gram tissue.[34] This results from the specific selection of the particle size 
and shape (i.e. particle geometry) that favors vascular deposition by increasing the 
interfacial adhesion interactions and reducing the dislodging hydrodynamic forces.[45]
B16-F10 cells were grown in the flank of a mouse for 10 – 15 days before the injection of 
5.0×108 nanoconstructs in 150 μL of phosphate buffered saline via tail vein. This dose 
corresponds to ~ 8 μg of USPIOs per mouse (i.e. ~ 0.5 mg of Fe/kg). Three different groups 
were considered: i) free 5 nm USPIOs with an external magnet (n = 3 mice); ii) 
nanoconstructs without an external magnet (n = 3 mice); and iii) nanoconstructs with an 
external magnet (n = 6 mice). The magnet was placed on the tumor side for 4h post injection 
and the comparison among the three groups was performed fixing the total amount of 
injected iron. The mice were imaged pre-injection as a control, at 4h, after the removal of 
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the magnet, and at 24h post injection, just before sacrifice using a 3T MRI clinical scanner. 
Figure 6 shows MR images and intensity ratios at the three different time points, and for the 
three experimental groups. The tumor is visible on the right flank of the animal. The top row 
is for the free USPIOs (Figure. 6a–d), the middle row is for the nanoconstructs without 
exposure to a magnet (Figure. 6e–h), and the bottom row is for the nanoconstructs exposed 
to a magnet (Figure. 6i–l). In this latest case, a significant enhancement in MRI contrast is 
evident with the appearance of large, dark spots within the tumor mass (Figure. 6j and k), 
which are not observed in the case of free USPIOs. The level of nanoconstruct accumulation 
has been also quantified by considering the intensity ratios over two different regions of 
interests (ROIs), namely the entire tumor mass (whole tumor mass, in Figure. 6) and the 
dark spots within the tumor mass (CA Accumulated Area, in Figure. 6). The intensity ratios 
(Figure. 6d, h, and l) are calculated as the difference between the intensity of the ROI and 
reference water divided by the intensity of the reference water. For the nanoconstructs 
dragged by a magnet (Figure. 6l), a significant drop in intensity ratio, up to 60%, was 
observed within the first 4h for both ROIs. In the absence of an external magnet, no 
significant changes in contrast was appreciated by looking directly at the MRI slides, but a 
slight decrease in intensity ratio (~20%) can be computed after 24h (Figure. 6h). For the free 
USPIOs in the presence of an external magnet, no statistically significant difference in 
intensity ratio is observed (Figure. 6d). Note that the intensity ratios were quantified over 
multiple planes, as described in the materials and methods and in the Supporting 
Information.
The absence of any significant contrast for the free USPIOs has to be certainly ascribed to 
the low dose of iron injected (~ 0.5 mg of Fe/kg). Indeed, this is at least 20 times lower than 
the doses commonly used in similar animal experiments and in clinical practice (10 mg of 
Fe/kg).[18] However, for the same doses, the magnetic nanoconstructs can induce a 
significant change in contrast, especially upon exposure to a static magnetic field. The 
intensity ratio clearly demonstrates that the contrast enhancement occurs mostly within the 
first 4h, during which the magnet is applied next to the tumor. It should also be emphasized 
that, given the size of the nanoconstructs, these are not expected to distribute throughout the 
tumor tissue to provide a uniform darkening of the tumor mass, but would rather accumulate 
within the tumor microvasculature as explained above. Thus, the significant darkening 
observed in Figure. 6j and k, and documented over multiple z-planes within the tumor mass 
(Supporting Information), should be related to the progressive accumulation of magnetic 
nanoconstructs, operating locally as vascular magnetic dipoles and attracting over time other 
nanoconstructs passing nearby. Dipole-dipole magnetic interactions arising among the 
nanoconstructs exposed to external static fields would contribute to their progressive 
deposition within the diseased vasculature and represent a novel, in vivo effective inter-
particle communication mechanism.[46]
Additional MR images are presented in the Supporting Information for the same animal of 
Figure. 6, on different planes, and for other mice used in this study. Histological sections of 
the tumor, liver, and spleen are shown in the Supporting Information, for two different 
stains, namely classical hematoxylin and eosin (H&E) stain and Prussian Blue (PB) stain. 
SiMPs appear as black dots in the H&E slides, with a diameter of ~ 1 μm. In the PB stained 
slides, the SIMPs appear darker than the surrounding tissue and are surrounded by bluish 
Gizzatov et al. Page 9
Adv Funct Mater. Author manuscript; available in PMC 2015 August 06.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
glows deriving from the Prussian blue staining of the iron. This demonstrates that the 
USPIOs are still associated with SiMPs. Even for the histological sections, it should be 
emphasized that, given the size of the nanoconstructs and the association of the USPIOs 
with the SiMPs, the PB staining is not expected to appear as uniform bluish layer coating the 
tissue slide but rather as discrete blue spots comparable in size with the SiMPs.
3. Conclusions
In summary, a novel class of magnetic nanoconstructs has been developed that could fully 
capitalize on the multifunctional properties of USPIOs. The proposed strategy is of broad 
applicability and decouples the IO functionality from their geometrical properties allowing 
the utilization of small, rapidly biodegradable 5 nm USPIOs for diverse functions. 
Cooperative accumulation at the target site; effective magnetic guidance, traditionally 
limited to large bulky particles; and MRI contrast enhancement, ~ 10-fold higher than 
conventional clinical systems, have been demonstrated by dispersing mesoscopic clusters of 
5 nm USPIOs within larger porous matrices made out either of silicon or polymers. The 
resulting magnetic nanoconstructs are capable of providing significant contrast already at 
iron doses 1 to 2 orders of magnitude smaller than current practice. This work also continues 
to prove that enhancement in relaxivity associated with the geometrical confinement of MRI 
contrast agents in mesoporous structures is an universal phenomenon, independent of the 
type of agents. This approach could be used to boost even more the already high relaxivities 
of iron nanocubes and doped iron oxide nanoparticles. The cooperative tumor accumulation 
of these nanoconstructs could be also used for triggering the release of large amounts of 
therapeutic cargos directly at the site of interest, and enabling thermal ablation therapies via 
systemic administration of iron oxide nanoparticles.
4. Experimental Section
Fabrication, loading and characterization of the mesoporous nanoconstructs
Details on the fabrication, loading and characterization of the discoidal mesoporous silicon 
particles (SiMPs) and discoidal polymeric nanoconstructs (DPNs) are provided in the 
Supporting Information.
Degradation of the SiMPs and USPIO release
The USPIO-loaded SiMPs were exposed to 1X phosphate buffered saline and left for 3, 6, 
and 24h in a shaking incubator at 60 rpm and 37 °C. Samples were centrifuged at 4,000 rpm 
and the supernatant was assessed for the presence of Fe using ICP-OES.
Relaxometric analysis
In vitro relaxation times were measured in a Bruker Minispec (mq 60) benchtop relaxometer 
operating at 60 MHz and 37 °C. The longitudinal (T1) relaxation times were obtained using 
inversion recovery pulse sequence. The transverse (T2) relaxation times were measured 
using Carr-Purcell-Meiboom-Gill (CPMG) sequence. In vitro T2-weighted MR phantom 
studies were performed in a clinical 3T scanner (Philips Ingenia®) using turbo spin echo 
(TSE) sequence with TR = 2,500 ms, TE = 100 ms and a slice thickness of 400 μm. For 
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phantom imaging, a known number of USPIO-loaded SiMPs were embedded in a 1% 
Agarose matrix.
Cell line and tumor model
B16-F10 cells (from ATCC, Rockville, MD, USA) were cultured in DMEM medium 
supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 mg/ml 
streptomycin, and maintained at 37°C in a 5% CO2 incubator. All the cell culture products 
were purchased from Invitrogen (Carlsbad, CA, USA). For the tumor model, 106 B16-F10 
cells in 200 μl PBS were injected subcutaneously into the flank of 12-weeks old male Nude 
mice (Nu/Nu) purchased from Charles River (Wilmington, MA, USA). Mice were kept on a 
12h light-dark cycle with food and water ad libitum. All animal experiments in this study 
were approved by the Institutional Animal Care & Use Committee (IACUC) of The 
Methodist Hospital Research Institute.
In vivo MR Imaging
10–15 days after tumor implantation, the mice were injected intravenously with either 5×108 
5 nm USPIO-loaded SiMPs or USPIOs alone (~ 8 μg) in 150 μL of 1X phosphate buffered 
saline, in the presence and in the absence of an external magnet (D401-N52, K&J Magnetics 
Inc.), placed on top of the tumor. After 4h, the magnet was removed and MR imaging were 
performed at 4 and 24h post injection. T2-weighted MR images were acquired in a 3T 
clinical scanner (Philips Ingenia®) using spin echo sequence with TR = 3,000 ms, TE = 100 
ms, and a slice thickness of 500 μM. FOV is 80×80 and reconstructed resolution matrix of 
512×512. All animal experiments performed were in line with the institutional guidelines on 
the ethical use of animals.
Histological analysis
The mice were sacrificed at 24h post nanoconstructs injection and their organs were 
removed and fixed in 10% Formalin for histological study. Transverse sections (4 μm in 
thickness) of paraffin-embedded tumors were stained with the Prussian blue (PB stain), to 
identify the accumulation of iron oxide; and with hematoxylin and eosin (H&E stain) to 
identify the presence of the SiMPs in the tissues. Sections were examined with a Nikon 
Eclipse 80i microscope using a 100x objective, and digital images were obtained with a 
CCD camera (Nikon digital sight DS-U3).
In vitro magnetic guidance experiments
A microfluidic system was used comprising a commercially available parallel plate flow 
chamber (Glycotech – Rockville, MD, U.S.A.) mounted on a 35 mm cover slip; a syringe 
pump (Harvard Apparatus, MA) and an epi-fluorescence inverted microscope (Nikon Ti-
Eclipse). After proper sonication, the solution of USPIO-loaded nanoconstructs (107/ml) 
was infused in the system with a shear rate of 25 s−1 (SiMPs) and 12 s−1 (DPNs). The 
magnetic guidance was performed by placing a discoidal magnet (D401-N52, K&J 
Magnetics Inc.) under the cover slip, before the flow was started. Additional details on the 
magnets and experiments are provided in the Supporting Information. Movies were taken 
during the experiments focusing on different regions of interest up to ~1,000 μm away from 
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the magnet. In-flow and drifting velocity have been calculated via offline analysis on the x 
and y displacement of particles in the time interval.
Molecular Dynamics computations
A fully periodic brick (11.3 × 11.06 × 4.32 nm3) of alpha-quartz (SiO2) was first considered 
with an 8 nm pore diameter. Inner surface of the pore was treated by adding silanol groups (-
Si-O-H), where necessary. We considered USPIOs (2.09 nm diameter) made of magnetite 
(Fe3O4) with hydroxyl groups (-O-H), where necessary. USPIO nanoparticles were inserted 
in midpoint-mirrored pairs. Numerical results were obtained using GROMACS 
(www.gromacs.org). The SPC/E model was used for describing water. Lennard-Jones 
potentials were treated with a twin-range cut-off and 1.5 nm cut-off distance, whereas for 
electrostatic interactions the Particle Mesh Ewald (PME) was used with 1.5 nm real-space 
cut-off, a 0.12 nm reciprocal space gridding, and splines of order 4 with 10−5 tolerance. 
Simulations were carried out with a third-order-in-space leap-frog algorithm and time step 
of dt = 0.5 fs. To determine the isotropic self-diffusion coefficient Dw of the water 
molecules, the mean square displacement (MSD) and the Einstein relation, applied to an 
average MSD over multiple time origins, were used.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Magnetic nanoconstructs and USPIOs distribution. a, Ultra small superparamagnetic iron 
oxide nanoparticles (USPIOs) are loaded within the porous structure of 1,000×400 nm 
discoidal silicon particles (SiMPs); 1,000×500 nm discoidal PLGA/PEG nanoconstructs 
(DPNs). Mesoscopic clusters of USPIOs are formed within the porous structure leading to 
multiscale, hierarchically structured magnetic nanoconstructs. Energy Dispersive X-Ray 
(EDX) – TEM mapping b for the SiMPs; c for the DPNs. These maps show the distribution 
of the most abundant element (i.e. silicon – Si –for the SiMPs and carbon – C –for the 
DPNs) and the dispersion of 5 nm USPIOs with the corresponding porous matrix (red dots 
in the third column). Note the formation of multiple, mesoscopic clusters of USPIOs within 
the two different matrices, one mesoporous silicon and one polymeric. (scale bar: 100 nm)
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Figure 2. 
USPIO loading and stability of the magnetic nanoconstructs. a, The mass of USPIOs loaded 
within the mesoporous nanoconstructs is measured via inductively coupled plasma optical 
emission spectroscopy (ICP-OES). b, The percentage of USPIOs released from a 
mesoporous SiMP is measured as a function of the incubation time in a buffer solution, 
agitated at 60 rpm and 37°C. c-e, Scanning electron micrographs showing the morphology 
of the SiMPs at three different incubation time points, namely 3, 6 and 24h. The inset in e, 
shows the uneven degradation of the SiMPs that tend to assume a mushroom shape. (scale 
bar: 1.0 μm)
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Figure 3. 
Relaxometric characterization of the magnetic nanoconstructs. a, The transversal (r2) and 
longitudinal (r1) relaxivities, and the r2/r1 ratio are listed for the free USPIOs and the 
corresponding USPIO-loaded nanoconstructs, as derived from a bench-top relaxometric 
analysis. The change in transversal relaxivity Δr2 and Δr2/r1 ratio is also provided, showing a 
significant enhancement in MRI performance for all configurations. Note that for the DPNs, 
the enhancement is calculated with respect to the hydrophilic 5 nm USPIOs. b, Phantom 
images for different concentrations of the 5 nm USPIO-loaded SiMPs (magnetic 
nanoconstructs) generated using a 3T Philips MRI clinical scanner. Note that 107 SiMPs are 
equivalent to ~ 0.2 μg of Fe.
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Figure 4. 
Molecular Dynamics simulation for the self-diffusion coefficient of water in a mesopore. a, 
Molecular Dynamics representation of an individual USPIO, a couple, 4 couples and 8 
couples of USPIOs adsorbed on the walls of a mesopore with a hydrated silicon surface. b, 
Computed diffusivity of the water molecules, averaged over the cross-section of the 
mesopore, presented as a function of the loading conditions (1, 4 and 8 couples of USPIOs 
per periodic slice of a mesopore, corresponding to 6%, 24% and 48% of the maximum 
geometrical loading) and strength of the Lennard-Jones potential. Error bars indicate 98% 
confidence intervals based on Student’s t distribution associated with four Dw measurements 
upon the achievement of steady state conditions. Variable LJ potentials allow one to explore 
the effects due to the actual surface properties (i.e. different pegylation levels).
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Figure 5. 
Remote guidance of the magnetic nanoconstructs and cooperative accumulation. a, 
Schematic of the parallel plate flow chamber apparatus used for testing the guidance of the 
magnetic nanoconstructs under controlled biophysical conditions. The static magnet was 
placed underneath the chamber, on the side and the nanoconstruct solution was infused via a 
syringe pump through the inlet bore. b, The variation of the longitudinal and transversal 
components of the nanoconstruct velocity, vx and vy, normalized with the chamber height h 
and wall shear rate S; and of the angle θ between the flow direction and the particle 
trajectory with the separation distance from the magnet. (black diamonds are for the SiMPs; 
triangles are for the DPNs) c, Image of a dark corona originating from the progressive 
accumulation of nanoconstructs around the magnet. d, Bright field microscopy images of 
SiMP nanoconstructs depositing on the bottom of the parallel plate flow chamber (S = 15−1 
sec). f, Fluorescent microscopy images of DPN nanoconstructs depositing on the bottom of 
the parallel plate flow chamber (S = 15−1 sec). e,g, Four representative nanoconstruct 
clusters are identified for the SiMPs and DPNs by dashed circles and their relative area 
variation ΔA% is plotted over time.
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Figure 6. 
MR imaging of the magnetic nanoconstructs accumulating in melanoma bearing mice. a-c, 
MR images of a melanoma tumor growing in the right flank of a mouse before, 4h, and 24h 
post injection of free 5 nm USPIOs, in the presence of a static magnet applied over the 
tumor. d, Intensity ratios at tumor region of interest (ROIs) estimated at 0, 4 and 24h post 
injection. e-g, MR images of a melanoma tumor growing in the right flank of a mouse 
before, 4h, and 24h post injection of magnetic nanoconstructs, in the absence of a static 
magnet applied over the tumor. h, Intensity ratios for two ROIs estimated at 0, 4 and 24h 
post injection. i-k, MR images of a melanoma tumor growing in the right flank of a mouse 
before, 4h, and 24h post injection of magnetic nanoconstructs, in the presence of a static 
magnet applied over the tumor. l, Intensity ratios for two ROIs estimated at 0, 4 and 24h 
post injection. Note that the intensity ratios have been calculated by averaging the MRI 
signal over multiple z-planes. A 3T Philips MRI clinical scanner was used. B16-F10 cells 
were grown in the flank of a mouse for 10 – 15 days prior injection of 5.0×108 
nanoconstructs via tail vein. This dose corresponds to ~ 8 μg of SPIOs per mouse (ie, ~ 0.5 
mg of Fe/kg).
Gizzatov et al. Page 21
Adv Funct Mater. Author manuscript; available in PMC 2015 August 06.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
